One main finding of this study is that there are differences in the CD4+ T cells immunological phenotypes of ADS clinical subsets, with a significant increase in CD4+ Th2 and Th17 cells following stimulation with rh-MOG in MOGAD children at onset of demyelinating events but not in MS and control patients. This evidence concerns the gene MOG and myeloid sarcoma.